An Investigation of ReNu™ Knee Injection in Patients With Osteoarthritis
Public ClinicalTrials.gov record NCT02318511. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Investigation of ReNu™ Knee Injection: Monitoring the Response of Knee Function and Pain in Patients With Osteoarthritis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Prospective, Randomized study evaluating the efficacy of ReNu for the treatment of Kellgren-Lawrence grade 2 or 3 osteoarthritis. Patients will be randomized into 1 of 3 groups for injection into the effected knee: 1) ReNu - study treatment, 2) Hyaluronic Acid (HA) injection - with commonly used injection material and 3) Saline. After treatment, patients will be followed up to 12 months to evaluate improvements using common pain and function subscales.
Study identification
- NCT ID
- NCT02318511
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Interventions
- Knee injection Procedure
- ReNu amniotic allograft Other
- placebo saline Device
- Hyaluronic Acid Device
Procedure · Other · Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2015 (Type not available)
- Primary completion
- Jan 2019 (Actual)
- Completion
- Feb 2019 (Actual)
- Last update posted
- Jan 18, 2020
2015 – 2019
United States locations
- U.S. sites
- 12
- U.S. states
- 11
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| American Sports Medicine Institute | Birmingham | Alabama | 35205 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| Midwest Orthopedics at Rush, LLC | Chicago | Illinois | 60612 | — |
| Orthoindy | Indianapolis | Indiana | 46143 | — |
| Center for Clinical and Translational Science UK Chandler Medical Center, Pavilion H | Lexington | Kentucky | 40536-2093 | — |
| Brigham and Women's Hospital | Chestnut Hill | Massachusetts | 02467 | — |
| Missouri Orthopaedic Institute (MOI) | Columbia | Missouri | 65212 | — |
| New Mexico Orthopaedics | Albuquerque | New Mexico | 87106 | — |
| New York University | New York | New York | 10003 | — |
| Hospital for Special Surgery | New York | New York | 10021 | — |
| The Ohio State University | Columbus | Ohio | 43221 | — |
| Advanced Orthopedics | Richmond | Virginia | 23294 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02318511, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 18, 2020 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02318511 live on ClinicalTrials.gov.